Clinical Decision Support Tools for Antibiotic Prescribing
NCT03580603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 273
Last updated 2021-05-06
Summary
The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.
Conditions
Interventions
- OTHER
-
Visualization tool
Visual representation of past microbiological culture data
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Steven Horng, MD · Beth Israel Deaconess Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-05
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
NCT03510351 ·Status: COMPLETED
-
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
NCT03489330 ·Status: COMPLETED
-
Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Enterobacterales Bacteremia
NCT06425367 ·Status: RECRUITING ·Phase: NA
-
Optimizing Clinical Use of Polymyxin B
NCT02682355 ·Status: COMPLETED
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
NCT03138733 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern
NCT01352377 ·Status: UNKNOWN
-
Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
NCT07226557 ·Status: ACTIVE_NOT_RECRUITING
-
Resistant Bacteria in Children in France
NCT06036628 ·Status: COMPLETED
-
Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
NCT01781182 ·Status: COMPLETED
-
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
NCT06069206 ·Status: COMPLETED ·Phase: NA
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
NCT00093067 ·Status: COMPLETED ·Phase: PHASE3
-
Shared Decision-making and Antimicrobial Stewardship in Secondary Care
NCT06605820 ·Status: RECRUITING
-
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
NCT05613322 ·Status: TERMINATED
-
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
NCT05696093 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
NCT02070757 ·Status: COMPLETED ·Phase: PHASE3
-
Oritavancin for CIED Infections With MDR Gram-positive Cocci
NCT07013552 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
NCT00414362 ·Status: COMPLETED
-
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
NCT00679835 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
NCT01283581 ·Status: COMPLETED ·Phase: PHASE2
-
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
NCT07302035 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria
NCT03903783 ·Status: COMPLETED ·Phase: NA
-
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
NCT06080698 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4